FMOD and neoplasm: To verify the oncogenic role of FMOD in driving OSCC progression in vivo, we established a xenograft OSCC tumor model by subcutaneous injection of CAL27-shFMOD-3 and CAL-27-shCON cells in nude mice and examined the growth of tumors.